| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Revenue | $102.30B | +1.1% |
| Cost of Revenue | $79.61B | +0.4% |
| Gross Profit | $22.69B | +3.6% |
| R&D Expense | $2.78B | +7.8% |
| SG&A Expense | $14.14B | -3.5% |
| Operating Income | $5.77B | +23.9% |
| Interest Expense | $1.22B | -20.8% |
| Pre-tax Income | $3.23B | -45.6% |
| Income Tax | $803.0M |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.61B | -9.2% |
| Accounts Receivable | $12.48B | -3.3% |
| Inventory | $4.78B | -19.0% |
| Current Assets | $42.35B | -6.0% |
| Total Assets | $89.61B | -3.4% |
| Current Liabilities | $51.65B | -8.1% |
| Long-term Debt | $29.59B | +9.8% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.56B | -65.4% |
| Capital Expenditures | $3.00B | +7.4% |
| Investing Cash Flow | -$3.02B | -331.5% |
| Financing Cash Flow | -$1.63B | +90.2% |
| Free Cash Flow | $562.0M | -92.5% |
| -18.1% |
| Net Income | $2.44B | -56.1% |
| Total Liabilities |
| $92.64B |
| -1.8% |
| Stockholders' Equity | -$3.12B | -85.3% |